However, within the ER-positive subgroup, 20.8% (37/178) of breast tumours were positive and there was a significant correlation with both overall survival (P = 0.0083) and disease-free survival (P = 0.0136) (Figure 6a,b, respectively). This evidence concerns the gene ESR1 and breast neoplasm.